Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From I-Hub (Nerverending)

<As for myself, I can say that I would never pay $3 a share for a PTSC with a mere $100M of retained earnings. I wouldn't even pay 25 cents a share for such a company.>

What if all future retained earnings were returned to shareholders? (which is what I expect to happen). Would that change your thinking about the value of a share?

Opty

Share
New Message
Please login to post a reply